A detailed history of Baxter Bros Inc transactions in Medtronic PLC stock. As of the latest transaction made, Baxter Bros Inc holds 5,700 shares of MDT stock, worth $455,259. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,700
Previous 6,514 12.5%
Holding current value
$455,259
Previous $512,000 0.2%
% of portfolio
0.07%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$76.84 - $91.03 $62,547 - $74,098
-814 Reduced 12.5%
5,700 $513,000
Q2 2024

Jul 15, 2024

SELL
$78.71 - $87.02 $47,225 - $52,212
-600 Reduced 8.43%
6,514 $512,000
Q1 2024

Apr 26, 2024

SELL
$82.84 - $88.09 $35,207 - $37,438
-425 Reduced 5.64%
7,114 $619,000
Q4 2023

May 17, 2024

BUY
$69.43 - $83.43 $29,507 - $35,457
425 Added 5.97%
7,539 $621,000
Q4 2023

Feb 06, 2024

SELL
$69.43 - $83.43 $5,207 - $6,257
-75 Reduced 0.99%
7,539 $621,000
Q3 2023

May 17, 2024

BUY
$78.22 - $90.4 $39,110 - $45,200
500 Added 7.03%
7,614 $596,000
Q3 2023

Oct 23, 2023

SELL
$78.22 - $90.4 $23,466 - $27,120
-300 Reduced 3.79%
7,614 $596,000
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $15,894 - $18,276
-200 Reduced 2.46%
7,914 $697,000
Q1 2023

May 15, 2023

SELL
$76.72 - $87.58 $14,576 - $16,640
-190 Reduced 2.29%
8,114 $654,000
Q4 2022

Jan 31, 2023

SELL
$76.18 - $87.74 $62,467 - $71,946
-820 Reduced 8.99%
8,304 $645,000
Q3 2022

Nov 10, 2022

BUY
$80.75 - $95.31 $64,600 - $76,248
800 Added 9.61%
9,124 $737,000
Q1 2022

Apr 20, 2022

BUY
$100.58 - $112.38 $50,290 - $56,190
500 Added 6.39%
8,324 $924,000
Q4 2021

Jan 14, 2022

SELL
$99.53 - $127.75 $39,812 - $51,100
-400 Reduced 4.86%
7,824 $809,000
Q3 2021

Oct 25, 2021

BUY
$122.75 - $135.17 $1.01 Million - $1.11 Million
8,224 New
8,224 $1.03 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $106B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Baxter Bros Inc Portfolio

Follow Baxter Bros Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.